The analysis revealed that IFI44 co-localizes effectively with both mesangial cells and podocytes in LN patients, indicating that either infiltrating inflammatory cells or renal cells express IFI44 (Figure 3). This evidence concerns the gene IFI44 and lobular neoplasia.